Stocks · Health care · Pharmaceutical Preparations

Olema Pharmaceuticals, Inc.

OLMA Clue Score20
United States Fiscal year ends December CIK 0001750284 Results filed 10 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Andrew Rappaport
21 Nov 2025
Director
Exercised, kept
35,868
$0.39
$13.99K
Naseem Zojwalla
16 Dec 2024
Chief Medical Officer
Exercised, kept
14,000
$4.87
$68.18K
Shane William Charles Kovacs
15 Nov 2024
Ch. Operating & Financial Off.
Exercised, kept
25,000
$7.02
$175.50K
Naseem Zojwalla
24 May 2024
Chief Medical Officer
Exercised, kept
9,460
$4.87
$46.07K
Naseem Zojwalla
18 Mar 2024
Chief Medical Officer
Exercised, kept
13,700
$4.87
$66.72K
Naseem Zojwalla
25 Jan 2024
Chief Medical Officer
Exercised, kept
20,000
$7.02
$140.40K
Shane William Charles Kovacs
12 Jan 2024
Ch. Operating & Financial Off.
Exercised, kept
50,000
$7.02
$351.00K
Shane William Charles Kovacs
12 Dec 2023
Ch. Operating & Financial Off.
Exercised, kept
10,000
$7.02
$70.20K
Naseem Zojwalla
11 Dec 2023
Chief Medical Officer
Exercised, kept
2,900
$7.02
$20.36K
Naseem Zojwalla
6 Dec 2023
Chief Medical Officer
Exercised, kept
13,100
$7.02
$91.96K
Kinney Horn
10 Feb 2022
Chief Business Officer
Exercised, kept
5,251
$2.06
$10.84K
Sean Bohen
23 Sep 2020
President and CEO
Exercised, kept
51,649
$4.82
$249.15K
Cynthia M Butitta
16 Sep 2020
Director
Exercised, kept
83,876
$4.41
$369.56K

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020